2021, WuXi STA Again Wins CMO Leadership Awards in All Six Core Categories
WuXi STA CMO Awards 2021
WuXi STA has been deeply involved in the CDMO industry for more than ten years. In the year of 2020 alone, WuXi STA served more than 470 customers worldwide, supporting 13 NDA approvals globally including 5 from US FDA, 4 from EU EMA, 2 from China NMPA and 2 from Japan PMDA. Dr. Minzhang Chen, CEO of WuXi STA, commented: “Thanks to our partners for their recognition of WuXi STA, and we will continue to leverage our end-to-end CMC platform, along with the global standard quality systems to empower more partners to accelerate their pathway to market for the benefit of global patients.”
STA Pharmaceutical Co., Ltd., (“WuXi STA”) , a leading Contract Development and Manufacturing Organization, announces that it has received 2021 CMO Leadership Awards in all six core categories including Capabilities, Compatibility, Expertise, Quality, Reliability and Service. This is the seventh time that WuXi STA has won the “CMO Leadership Awards” and the second time being recognized in all six core categories, which fully recognizes the outstanding achievements and contributions by WuXi STA in building quality system meeting global regulatory standards and providing efficient, flexible and high-quality solutions with integrated CMC (Chemical, Manufacturing, and Control) services.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance